Evidence map›Paper›PMID 42345194›Full record

ReviewNucleic acids research2026

Caveat emptor: predicting and modeling protein-DNA recognition and binding via machine-learning computational approaches.

Morgan A Esler, Rachel Werther, Lindsey A Doyle, Natalia C Ubilla-Rodriguez, Jeanette S Schwensen, Jazmine P Hallinan, Abigail R Lambert, Juliana C Young, Miriam Silverstein, Barry L Stoddard

Abstract readReview
In one paragraph

Review in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Morgan A EslerDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Rachel WertherDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.ORCID 0000-0002-3058-1550
Lindsey A DoyleDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.ORCID 0000-0002-0008-473X
Natalia C Ubilla-RodriguezDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Jeanette S SchwensenDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Jazmine P HallinanDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Abigail R LambertDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Juliana C YoungDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Miriam SilversteinDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.
Barry L StoddardDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., Seattle, WA 98109, United States.ORCID 0000-0001-5174-7858

Funding

Biophysical and structural studies of protein and enzyme mechanism, evolution, and engineeringR35GM148166 · NIGMS · FRED HUTCHINSON CANCER CENTER · PI BARRY L. STODDARD · 2023 to 2026
$2.3M
Acquisition of a Rigaku XtaLAB Synergy-R macromolecular diffraction instrumentation at Fred Hutchinson Cancer Research CenterS10OD028581 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2020 to 2020
$600k
Advanced Light SourceDepartment of Energy Office of Science User Facility AC02-05CH11231Fred Hutchinson Cancer CenterFred Hutchinson Cancer Center NIGMS R35 GM148166NIGMS NIH HHS GM124169-01NIGMS NIH HHS R35 GM148166NIH HHS S10OD028581
6 · The paper itself

Abstract

The recent development of AI-based predictive tools, such as AlphaFold3, for the prediction of the structures of biological molecules and their complexes has transformed modern molecular and cellular biology. While it displays exceptional accuracy in the modeling of folded protein domains and subunits, as well as larger protein-protein complexes and assemblages, AlphaFold3's performance in predicting the details of protein-DNA (or more broadly, protein-nucleic acid) contacts and complexes is less well established. Here we summarize the recent development and performance of tools intended to predict, model, and/or design protein:DNA recognition and contacts, and then demonstrate (using a well-defined system that offers a minimal "degree of difficulty") the issues that often surround the use of a resource such as AlphaFold3 for predicting protein:DNA interactions. Beyond providing a cautionary tale for casual users, we note that the incorporation of hybrid models of protein-DNA complexes (in which computationally predicted models are docked into low-resolution CryoEM density maps with little further refinement or quality control) into future training sets may lead to an ongoing and inappropriate learning cycle that further encourages such tools to generate new, equally inaccurate models of protein-DNA complexes.

Indexed as

Computational BiologyDNADNA-Binding ProteinsMachine LearningSoftwareModels, MolecularPredictive Learning ModelsProtein BindingDNADNA-Binding Proteins

Identifiers

PMID42345194
PMCPMC13294676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.